Renovatio Clinical — Houston, Texas

Renovatio Clinical is a clinical research site located in Houston, Texas, United States 77380.

Crixeo Clinical Trials Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Renovatio Clinical has participated in 9 clinical trials.

Therapeutic areas: Alpha 1-Antitrypsin Deficiency, Metastatic Breast Cancer, Alpha1-Antitrypsin Deficiency.

Sponsors: Vertex Pharmaceuticals Incorporated, Eli Lilly and Company, Suzhou Kintor Pharmaceutical Inc,.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Renovatio Clinical?

Renovatio Clinical has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Renovatio Clinical conducted?

Renovatio Clinical has 9 clinical trials on record. Their work covers Alpha 1-Antitrypsin Deficiency, Metastatic Breast Cancer, Alpha1-Antitrypsin Deficiency.

Is Renovatio Clinical accredited by Crixeo Clinical Trials?

Renovatio Clinical has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Renovatio Clinical?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.